Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 52
Filtrer
Plus de filtres











Gamme d'année
1.
Org Biomol Chem ; 22(23): 4637-4640, 2024 06 12.
Article de Anglais | MEDLINE | ID: mdl-38716558

RÉSUMÉ

Jamaicamide B was isolated from the cyanobacterium Moorea producens in Jamaica and shows neurotoxicity. This unique mixed peptide-polyketide structure contains a pyrrolinone ring, a ß-methoxy enone, an (E)-olefin, an undetermined stereocenter at C9, an (E)-chloroolefin, and a terminal alkyne. We report herein the first total synthesis and structural confirmation of the marine natural product (9R)-jamaicamide B.


Sujet(s)
Cyanobactéries , Cyanobactéries/composition chimique , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Stéréoisomérie , Structure moléculaire
2.
Colloq. Agrar ; 18(4): 53-60, jul.-dez. 2022.
Article de Anglais | VETINDEX | ID: biblio-1432778

RÉSUMÉ

The problems generated by the inappropriate use of agrotoxins and imported and costly chemical products to guarantee the health of the plants have been a great challenge for Brazilian farmers. The growing development and supply of new products of biological origin on the market is strengthening the portfolio of available bio-inputs for the production system. Among the benefits of the use of bioinputs is the greater sustainability of the productive system, with less frequent outbreaks of pests, reduction in application costs, greater efficiency of biological nitrogen fixation and promotion of plant growth. These benefits will promote greater profitability and contribute to a more sustainable agriculture. In this way, this review intends to discover some of the techniques that can be used in agriculture within two preceitos of sustainable agriculture.(AU)


Os problemas gerados pelo uso inadequado de agrotóxicos e produtos químicos importados e custosos para garantir a sanidade das plantas têm sido um grande desafio para os agricultores brasileiros. O crescente desenvolvimento e oferta de novos produtos de origem biológica no mercado vêm fortalecendo o portfólio de bioinsumos disponíveis para o sistema de produção. Entre os benefíciosda utilização de bioinsumos está a maior sustentabilidade do sistema produtivo, com surtos de pragas menos frequentes, redução dos custos de aplicação, maior eficiência da fixação biológica de nitrogênio e promoção de crescimento de plantas. Esses benefícios irão propiciar maior lucratividade e contribuir para uma agricultura mais sustentável. Dessa forma, esta revisão tem o intuito de descrever algumas das técnicas que podem ser utilizadas na agricultura dentro dos preceitos da agricultura sustentável.(AU)


Sujet(s)
Produits biologiques/synthèse chimique , Agriculture biologique/méthodes , Fixation de l'azote , Indicateurs de Développement Durable
3.
Molecules ; 26(23)2021 Nov 23.
Article de Anglais | MEDLINE | ID: mdl-34885649

RÉSUMÉ

American trypanosomiasis (Chagas disease) caused by the Trypanosoma cruzi parasite, is a severe health problem in different regions of Latin America and is currently reported to be spreading to Europe, North America, Japan, and Australia, due to the migration of populations from South and Central America. At present, there is no vaccine available and chemotherapeutic options are reduced to nifurtimox and benznidazole. Therefore, the discovery of new molecules is urgently needed to initiate the drug development process. Some acetophenones and chalcones, as well as chromane-type substances, such as chromones and flavones, are natural products that have been studied as trypanocides, but the relationships between structure and activity are not yet fully understood. In this work, 26 compounds were synthesized to determine the effect of hydroxyl and isoprenyl substituents on trypanocide activity. One of the compounds showed interesting activity against a resistant strain of T. cruzi, with a half effective concentration of 18.3 µM ± 1.1 and an index of selectivity > 10.9.


Sujet(s)
Acétophénones/pharmacologie , Produits biologiques/pharmacologie , Maladie de Chagas/métabolisme , Chalcones/pharmacologie , 4H-1-Benzopyran-4-ones/pharmacologie , Découverte de médicament/méthodes , Flavones/pharmacologie , Trypanocides/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Acétophénones/synthèse chimique , Produits biologiques/synthèse chimique , Survie cellulaire/effets des médicaments et des substances chimiques , Maladie de Chagas/parasitologie , Chalcones/synthèse chimique , 4H-1-Benzopyran-4-ones/synthèse chimique , Flavones/synthèse chimique , Humains , Trypanocides/synthèse chimique , Cellules U937
4.
Biomolecules ; 11(12)2021 12 01.
Article de Anglais | MEDLINE | ID: mdl-34944448

RÉSUMÉ

Acquired immunodeficiency syndrome (AIDS) caused by the human immunodeficiency virus (HIV) continues to be a public health problem. In 2020, 680,000 people died from HIV-related causes, and 1.5 million people were infected. Antiretrovirals are a way to control HIV infection but not to cure AIDS. As such, effective treatment must be developed to control AIDS. Developing a drug is not an easy task, and there is an enormous amount of work and economic resources invested. For this reason, it is highly convenient to employ computer-aided drug design methods, which can help generate and identify novel molecules. Using the de novo design, novel molecules can be developed using fragments as building blocks. In this work, we develop a virtual focused compound library of HIV-1 viral protease inhibitors from natural product fragments. Natural products are characterized by a large diversity of functional groups, many sp3 atoms, and chiral centers. Pseudo-natural products are a combination of natural products fragments that keep the desired structural characteristics from different natural products. An interactive version of chemical space visualization of virtual compounds focused on HIV-1 viral protease inhibitors from natural product fragments is freely available in the supplementary material.


Sujet(s)
Produits biologiques/synthèse chimique , Inhibiteurs de protéase du VIH/synthèse chimique , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/enzymologie , Syndrome d'immunodéficience acquise/traitement médicamenteux , Syndrome d'immunodéficience acquise/virologie , Produits biologiques/composition chimique , Produits biologiques/pharmacologie , Ordinateurs , Bases de données pharmaceutiques , Conception de médicament , Inhibiteurs de protéase du VIH/composition chimique , Inhibiteurs de protéase du VIH/pharmacologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , Humains , Structure moléculaire , Relation structure-activité
5.
Curr Top Med Chem ; 21(22): 2046-2069, 2021.
Article de Anglais | MEDLINE | ID: mdl-34525920

RÉSUMÉ

BACKGROUND: Naphthoquinones are a class of aromatic compounds relevant for their chemical characteristics, structural properties, and biological activity. These compounds are found in nature with a wide range of effects, highlighting their antibacterial, antifungal, and antiprotozoal properties. Additionally, naphthoquinones are used as a scaffold to obtain new derivatives with pharmacological potential, mainly compounds against parasitic diseases. OBJECTIVE: The purpose of this work was to carry out a comprehensive review of naphthoquinones and their derivatives obtained from both natural and synthetic sources, also, to analyze their biological activity against Leishmania spp. (Leishmaniasis), Trypanosoma cruzi (Chagas disease), Plasmodium falciparum (Malaria), Toxoplasma gondii (Toxoplasmosis), and Toxocara canis (Toxocariasis). All of these agents are responsible for relevant diseases worldwide. RESULTS: Natural naphthoquinones, such as plumbagin, diospyrin, burmanin, lapachol, lawsone and psychorubrin, show an antiprotozoal activity similar or enhanced antiprotozoal activity to reference drugs. Some naphthoquinones obtained by synthesis or semi-synthesis showed better biological activity or less toxic effects than natural compounds. CONCLUSION: In this review, natural and synthetic naphthoquinones showed antiparasitic activity, in most cases, with improved results than current drugs currently used in clinical trials. A modification of their structure with different functional groups can enhance their biological effects, improve solubility, and reduce undesirable side effects. Therefore, naphthoquinones are important molecules in the development of new chemotherapeutic agents against parasitic diseases.


Sujet(s)
Anti-infectieux/synthèse chimique , Produits biologiques/synthèse chimique , Produits biologiques/pharmacologie , Naphtoquinones/synthèse chimique , Naphtoquinones/pharmacologie , Maladies parasitaires/traitement médicamenteux , Animaux , Anti-infectieux/pharmacologie , Humains , Leishmania/effets des médicaments et des substances chimiques , Plasmodium falciparum/effets des médicaments et des substances chimiques , Toxocara canis/effets des médicaments et des substances chimiques , Toxoplasma/effets des médicaments et des substances chimiques , Trypanosoma cruzi/effets des médicaments et des substances chimiques
6.
Bioorg Chem ; 111: 104893, 2021 06.
Article de Anglais | MEDLINE | ID: mdl-33882364

RÉSUMÉ

To date, Alzheimer's disease is the most alarming neurodegenerative disorder worldwide. This illness is multifactorial in nature and cholinesterase inhibitors have been the ones used in clinical treatments. In this context, many of these drugs selectively inhibit the acetylcholinesterase enzyme interacting in both the active site and the peripheric anionic site. Besides, some agents have exhibited extensive benefits being able to co-inhibit butyrylcholinesterase. In this contribution, a strategy previously explored by numerous authors is reported; the synthesis of hybrid cholinesterase inhibitors. This strategy uses a molecule of recognized high inhibitory activity (tacrine) together with a steroidal alkaloid of natural origin using different connectors. The biological assays demonstrated the improvement in the inhibitory activity compared to the alkaloidal precursor, together with the reinforcement of the interactions in multiple sites of the enzymatic cavity. This strategy should be explored and exploited in this area. Docking and molecular dynamic studies were performed to explain enzyme-ligand interactions, assisting a structure-activity relationship analysis.


Sujet(s)
Alcaloïdes/pharmacologie , Produits biologiques/pharmacologie , Anticholinestérasiques/pharmacologie , Conception de médicament , Stéroïdes/pharmacologie , Acetylcholinesterase/métabolisme , Alcaloïdes/synthèse chimique , Alcaloïdes/composition chimique , Animaux , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Butyrylcholine esterase/métabolisme , Anticholinestérasiques/synthèse chimique , Anticholinestérasiques/composition chimique , Relation dose-effet des médicaments , Electrophorus , Equus caballus , Structure moléculaire , Stéroïdes/synthèse chimique , Stéroïdes/composition chimique , Relation structure-activité
7.
Arch Pharm (Weinheim) ; 354(8): e2100034, 2021 Aug.
Article de Anglais | MEDLINE | ID: mdl-33913195

RÉSUMÉ

Among peptide-based drugs, naturally occurring bicyclic compounds have been established as molecules with unique therapeutic potential. The diverse pharmacological activities associated with bicyclic peptides from marine tunicates, sponges, and bacteria render them suitable to be employed as effective surrogate between complex and small therapeutic moieties. Bicyclic peptides possess greater conformational rigidity and higher metabolic stability as compared with linear and monocyclic peptides. The antibody-like affinity and specificity of bicyclic peptides enable their binding to the challenging drug targets. Bridged macrobicyclic peptides from natural marine resources represent an underexplored class of molecules that provides promising platforms for drug development owing to their biocompatibility, similarity, and chemical diversity to proteins. The present review explores major marine-derived bicyclic peptides including disulfide-bridged, histidinotyrosine-bridged, or histidinoalanine-bridged macrobicyclic peptides along with their structural characteristics, synthesis, structure-activity relationship, and bioproperties.The comparison of these macrobicyclic congeners with linear/monocyclic peptides along with their therapeutic potential are also briefly discussed.


Sujet(s)
Organismes aquatiques/métabolisme , Produits biologiques/pharmacologie , Peptides cycliques/pharmacologie , Animaux , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Développement de médicament , Humains , Peptides cycliques/synthèse chimique , Peptides cycliques/composition chimique , Relation structure-activité
8.
ChemMedChem ; 16(12): 1945-1955, 2021 06 17.
Article de Anglais | MEDLINE | ID: mdl-33682316

RÉSUMÉ

In this work, we describe how stereochemically complex polycyclic compounds can be generated by applying a synthetic sequence comprising an intramolecular Ugi reaction followed by a Pictet-Spengler cyclization on steroid-derived scaffolds. The resulting compounds, which combine a fragment derived from a natural product and a scaffold not found in nature. are both structurally distinct and globally similar to natural products at the same time, and interrogate an alternative region of the chemical space. One of the new compounds showed significant antiproliferative activity on HepG2 cells through a caspase-independent cell-death mechanism, an appealing feature when new antitumor compounds are searched.


Sujet(s)
Antinéoplasiques/pharmacologie , Produits biologiques/pharmacologie , Caspases/métabolisme , Isoquinoléines/pharmacologie , Pipérazines/pharmacologie , Stéroïdes/pharmacologie , Antinéoplasiques/synthèse chimique , Antinéoplasiques/composition chimique , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Mort cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Tests de criblage d'agents antitumoraux , Cellules HepG2 , Humains , Isoquinoléines/synthèse chimique , Isoquinoléines/composition chimique , Structure moléculaire , Pipérazines/synthèse chimique , Pipérazines/composition chimique , Stéréoisomérie , Stéroïdes/synthèse chimique , Stéroïdes/composition chimique
9.
ChemMedChem ; 16(12): 1835-1860, 2021 06 17.
Article de Anglais | MEDLINE | ID: mdl-33682360

RÉSUMÉ

Chronic myeloid leukemia (CML) is a neoplasm characterized by BCR-ABL1, an oncoprotein with vital role in leukemogenesis. Its inhibition by tyrosine kinase inhibitors represents the main choice of treatment. However, therapeutic failure is worrying given the lack of pharmacological options. Pentacyclic triterpenes are phytochemicals with outstanding antitumoral properties and have also been explored as a basis for the design of potential leads. In this review, we have gathered and discuss data regarding both natural and semisynthetic pentacyclic triterpenes applied to CML cell treatment. We found consistent evidence that the class of pentacyclic triterpenes in general exerts promising pro-apoptotic and antiproliferative activities in sensitive and resistant CML cells, and thus represents a rich source for drug development. We also analyze the predicted drug-like properties of the molecules, discuss the structural changes with biological implications and show the great opportunities this class represents, as well as the perspectives they provide on drug discovery for CML treatment.


Sujet(s)
Antinéoplasiques d'origine végétale/pharmacologie , Produits biologiques/pharmacologie , Leucémie myéloïde chronique BCR-ABL positive/traitement médicamenteux , Triterpènes pentacycliques/pharmacologie , Inhibiteurs de protéines kinases/pharmacologie , Antinéoplasiques d'origine végétale/synthèse chimique , Antinéoplasiques d'origine végétale/composition chimique , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Prolifération cellulaire/effets des médicaments et des substances chimiques , Résistance aux médicaments antinéoplasiques/effets des médicaments et des substances chimiques , Tests de criblage d'agents antitumoraux , Humains , Leucémie myéloïde chronique BCR-ABL positive/métabolisme , Structure moléculaire , Triterpènes pentacycliques/synthèse chimique , Triterpènes pentacycliques/composition chimique , Inhibiteurs de protéines kinases/synthèse chimique , Inhibiteurs de protéines kinases/composition chimique
10.
Angew Chem Int Ed Engl ; 60(24): 13536-13541, 2021 06 07.
Article de Anglais | MEDLINE | ID: mdl-33768597

RÉSUMÉ

Brasilicardin A (1) consists of an unusual anti/syn/anti-perhydrophenanthrene skeleton with a carbohydrate side chain and an amino acid moiety. It exhibits potent immunosuppressive activity, yet its mode of action differs from standard drugs that are currently in use. Further pre-clinical evaluation of this promising, biologically active natural product is hampered by restricted access to the ready material, as its synthesis requires both a low-yielding fermentation process using a pathogenic organism and an elaborate, multi-step total synthesis. Our semi-synthetic approach included a) the heterologous expression of the brasilicardin A gene cluster in different non-pathogenic bacterial strains producing brasilicardin A aglycone (5) in excellent yield and b) the chemical transformation of the aglycone 5 into the trifluoroacetic acid salt of brasilicardin A (1 a) via a short and straightforward five-steps synthetic route. Additionally, we report the first preclinical data for brasilicardin A.


Sujet(s)
Aminosides/métabolisme , Génie génétique , Immunosuppresseurs/synthèse chimique , Alkyl et aryl transferases/génétique , Aminosides/synthèse chimique , Aminosides/composition chimique , Aminosides/pharmacologie , Animaux , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Produits biologiques/métabolisme , Produits biologiques/pharmacologie , Lignée cellulaire , Survie cellulaire/effets des médicaments et des substances chimiques , Humains , Immunosuppresseurs/composition chimique , Immunosuppresseurs/métabolisme , Immunosuppresseurs/pharmacologie , Souris , Plasmides/génétique , Plasmides/métabolisme , Streptomyces/génétique , Streptomyces/métabolisme , Terpènes/composition chimique
11.
Future Med Chem ; 12(17): 1533-1546, 2020 09.
Article de Anglais | MEDLINE | ID: mdl-32820960

RÉSUMÉ

Aim: Eight coumarin derivatives (1a-h) obtained from natural (-)-mammea A/BB (1) and 13 synthetic coumarins (2-14) had their cytotoxicity and biological activity evaluated against Mycobacterium tuberculosis H37Rv reference strain and multidrug-resistant clinical isolates. Materials & methods: Anti-M. tuberculosis activity was evaluated by resazurin microtiter assay plate, and the cytotoxicity of natural and synthetic products using J774A.1 macrophages by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Results: Compounds 1g, 5, 6, 12 and 14 were more active against M. tuberculosis H37Rv and multidrug-resistant clinical isolates with MIC values ranging from 15.6 to 62.5 µg/ml. Conclusion: These results demonstrate that the coumarin derivatives were active against multidrug-resistant clinical isolates, becoming potential candidates to be used in the treatment of resistant tuberculosis.


Sujet(s)
Antituberculeux/pharmacologie , Produits biologiques/pharmacologie , Coumarines/pharmacologie , Mycobacterium tuberculosis/effets des médicaments et des substances chimiques , Animaux , Antituberculeux/synthèse chimique , Antituberculeux/composition chimique , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Calophyllum/composition chimique , Cellules cultivées , Coumarines/synthèse chimique , Coumarines/composition chimique , Macrophages/effets des médicaments et des substances chimiques , Souris , Tests de sensibilité microbienne , Structure moléculaire , Extraits de plantes
12.
J Nat Prod ; 83(4): 1309-1313, 2020 04 24.
Article de Anglais | MEDLINE | ID: mdl-32233438

RÉSUMÉ

The synthesis of the biologically active alkaloid simulenoline, isolated from the roots of Zanthoxylum simulans, is reported. The natural product was assembled from simple commercial reagents via initial domino Knoevenagel/oxa-6π-electrocyclization followed by a one-pot singlet-oxygen ene-reaction/reduction sequence. New insights of singlet oxygen reactivity with olefinic substrates have been revealed.


Sujet(s)
Alcaloïdes/synthèse chimique , Alcènes/composition chimique , Produits biologiques/synthèse chimique , Oxygène singulet/composition chimique , Zanthoxylum/composition chimique , Alcaloïdes/composition chimique , Biomimétique , Cyclisation , Structure moléculaire , Oxydoréduction
13.
Sci Rep ; 10(1): 5467, 2020 03 25.
Article de Anglais | MEDLINE | ID: mdl-32214193

RÉSUMÉ

Neolignan licarin A (1) was isolated from leaves of Nectandra oppositifolia (Lauraceae) and displayed activity against trypomastigote forms of the etiologic agent of American trypanosomiasis, Trypanosoma cruzi. Aiming for the establishment of SAR, five different compounds (1a - 1e) were prepared and tested against T. cruzi. The 2-allyl derivative of licarin A (1d) exhibited higher activity against trypomastigotes of T. cruzi (IC50 = 5.0 µM and SI = 9.0), while its heterocyclic derivative 1e displayed IC50 of 10.5 µM and reduced toxicity against NCTC cells (SI > 19.0). However, these compounds presented limited oral bioavailability estimation (<85%, Papp <1.0 × 10-6 cm/s) in parallel artificial membrane permeability assays (PAMPA) due to excessive lipophilicity. Based on these results, different simplified structures of licarin A were designed: vanillin (2), vanillyl alcohol (3), isoeugenol (4), and eugenol (5), as well as its corresponding methyl (a), acetyl (b), O-allyl (c), and C-allyl (d) analogues. Vanillin (2) and its acetyl derivative (2b) displayed expressive activity against intracellular amastigotes of T. cruzi with IC50 values of 5.5 and 5.6 µM, respectively, and reduced toxicity against NCTC cells (CC50 > 200 µM). In addition, these simplified analogues showed a better permeability profile (Papp > 1.0 × 10-6 cm/s) on PAMPA models, resulting in improved drug-likeness. Vanillyl alcohol acetyl derivative (3b) and isoeugenol methyl derivative (4a) displayed activity against the extracellular forms of T. cruzi (trypomastigotes) with IC50 values of 5.1 and 8.8 µM respectively. Based on these results, compounds with higher selectivity index against extracellular forms of the parasite (1d, 1e, 3d, and 4a) were selected for a mechanism of action study. After a short incubation period (1 h) all compounds increased the reactive oxygen species (ROS) levels of trypomastigotes, suggesting cellular oxidative stress. The ATP levels were increased after two hours of incubation, possibly involving a high energy expenditure of the parasite to control the homeostasis. Except for compound 4a, all compounds induced hyperpolarization of mitochondrial membrane potential, demonstrating a mitochondrial imbalance. Considering the unique mitochondria apparatus of T. cruzi and the lethal alterations induced by structurally based on licarin A, these compounds are interesting hits for future drug discovery studies in Chagas disease.


Sujet(s)
Antiparasitaires/isolement et purification , Antiparasitaires/pharmacologie , Produits biologiques/isolement et purification , Maladie de Chagas/traitement médicamenteux , Lauraceae/composition chimique , Lignanes/isolement et purification , Lignanes/pharmacologie , Feuilles de plante/composition chimique , Trypanocides/isolement et purification , Trypanocides/pharmacologie , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Animaux , Antiparasitaires/synthèse chimique , Produits biologiques/synthèse chimique , Produits biologiques/pharmacologie , Découverte de médicament , Lignanes/synthèse chimique , Stress oxydatif/effets des médicaments et des substances chimiques , Phytothérapie , Espèces réactives de l'oxygène/métabolisme , Relation structure-activité , Trypanocides/synthèse chimique , Trypanosoma cruzi/métabolisme
14.
15.
Comput Biol Chem ; 79: 36-47, 2019 Apr.
Article de Anglais | MEDLINE | ID: mdl-30710804

RÉSUMÉ

Trypanosoma cruzi Trypanothione Reductase (TcTR) is one of the therapeutic targets studied in the development of new drugs against Chagas' disease. Due to its biodiversity, Brazil has several compounds of natural origin that were not yet properly explored in drug discovery. Therefore, we employed the Virtual Screening against TcTR aiming to discover new inhibitors from the Natural Products Database of the Bahia Semi-Arid region (NatProDB). This database has a wide chemical diversity favoring the discovery of new chemical entities. Subsequently, we analyzed the best docking conformations using self-organizing maps (AuPosSOM) aiming to verify their interaction sites at TcTR. Finally, the Pred-hERG, the Aggregator Advisor, the FAF-DRUGS and the pkCSM results allowed us to evaluate, respectively, the cardiotoxicity, aggregation capacity, presence of false positives (PAINS) and its toxicity. Thus, we selected three molecules that could be tested in in vitro assays in the hope that the computational results reported here would favor the development of new anti-chagasic drugs.


Sujet(s)
Antiprotozoaires/pharmacologie , Produits biologiques/pharmacologie , Simulation numérique , Bases de données chimiques , Évaluation préclinique de médicament , Antienzymes/pharmacologie , NADH, NADPH oxidoreductases/antagonistes et inhibiteurs , Trypanosoma cruzi/effets des médicaments et des substances chimiques , Antiprotozoaires/synthèse chimique , Antiprotozoaires/composition chimique , Produits biologiques/synthèse chimique , Produits biologiques/composition chimique , Brésil , Maladie de Chagas/traitement médicamenteux , Maladie de Chagas/métabolisme , Maladie de Chagas/parasitologie , Relation dose-effet des médicaments , Antienzymes/synthèse chimique , Antienzymes/composition chimique , Humains , Ligands , Modèles moléculaires , Structure moléculaire , NADH, NADPH oxidoreductases/métabolisme , Tests de sensibilité parasitaire , Relation structure-activité , Trypanosoma cruzi/enzymologie
16.
Curr Org Synth ; 16(1): 112-129, 2019.
Article de Anglais | MEDLINE | ID: mdl-31965925

RÉSUMÉ

BACKGROUND: 3,4-dihydroisocoumarins are an important small group belonging to the class of naturally occurring lactones isolated from different bacterial strains, molds, lichens, and plants. The structures of these natural compounds show various types of substitution in their basic skeleton and this variability influences deeply their biological activities. These lactones are structural subunits of several natural products and serve as useful intermediates in the synthesis of different heterocyclic molecules, which exhibit a wide range of biological activities, such as anti-inflammatory, antiplasmodial, antifungal, antimicrobial, antiangiogenic and antitumoral activities, among others. Their syntheses have attracted attention of many researchers reporting many synthetic strategies to achieve 3,4-dihydroisocoumarins and other related structures. OBJECTIVE: In this context, the isolation of these natural compounds from different sources, their syntheses and biological activities are reviewed, adding the most recent advances and related developments. CONCLUSION: This review aims to encourage further work on the isolation and synthesis of this class of natural products. It would be beneficial for synthetic as well as the medicinal chemists to design selective, optimized dihydroisocoumarin derivatives as potential drug candidates, since dihydroisocoumarin scaffolds have significant utility in the development of therapeutically relevant and biologically active compounds.


Sujet(s)
Produits biologiques/pharmacologie , Isocoumarines/pharmacologie , Bactéries/composition chimique , Produits biologiques/synthèse chimique , Produits biologiques/isolement et purification , Champignons/composition chimique , Isocoumarines/synthèse chimique , Isocoumarines/isolement et purification , Plantes/composition chimique
17.
Nat Prod Rep ; 36(2): 354-401, 2019 02 20.
Article de Anglais | MEDLINE | ID: mdl-30090891

RÉSUMÉ

Covering: 2006 to 2018 The application of the 6π-azaelectrocyclization of azatrienes as a key strategy for the synthesis of natural products, their analogs and related bioactive or biomedically-relevant compounds (from 2006 to date) is comprehensively reviewed. Details about reaction optimization studies, relevant reaction mechanisms and conditions are also discussed.


Sujet(s)
Alcaloïdes/synthèse chimique , Produits biologiques/synthèse chimique , Techniques de chimie synthétique/méthodes , Composés aza/composition chimique , Cyclisation , Agonistes histaminergiques/synthèse chimique , Pipéridines/composition chimique , Pyridines/composition chimique , Pyrroles/synthèse chimique , Quinazolines/synthèse chimique , Quinolizines/composition chimique , Sesquiterpènes/synthèse chimique
19.
An Acad Bras Cienc ; 90(1 Suppl 2): 1131-1174, 2018.
Article de Anglais | MEDLINE | ID: mdl-29873673

RÉSUMÉ

We present a comprehensive review of the advent and impact of continuous flow chemistry with regard to the synthesis of natural products and drugs, important pharmaceutical products and definitely responsible for a revolution in modern healthcare. We detail the beginnings of modern drugs and the large scale batch mode of production, both chemical and microbiological. The introduction of modern continuous flow chemistry is then presented, both as a technological tool for enabling organic chemistry, and as a fundamental research endeavor. This part details the syntheses of bioactive natural products and commercial drugs.


Sujet(s)
Automatisation/méthodes , Produits biologiques/composition chimique , Conception de médicament , Préparations pharmaceutiques/composition chimique , Technologie pharmaceutique/méthodes , Produits biologiques/synthèse chimique , Chimie pharmaceutique , Préparations pharmaceutiques/synthèse chimique
20.
An Acad Bras Cienc ; 90(1 Suppl 2): 1089-1099, 2018.
Article de Anglais | MEDLINE | ID: mdl-29873675

RÉSUMÉ

The synthesis of 3,3-disubstituted N-methyloxindoles, starting from 3-acetyl-2-hydroxy-1-methyloxindole employing a sequential one-pot synthesis, is studied. The process involves a first alkylation in the presence of 1 equiv. of both organic halide and Triton B and the second one employs another 1.5 equiv. of each in moderate to high yields. This procedure is compared with the results obtained from the direct dialkylation of N-methyloxindole. The metathesis of one of the corresponding diallylated product was also studied obtaining the spiranic oxindole. All these methodologies are directed towards the access to anticancer agents and natural biologically active products.


Sujet(s)
Antinéoplasiques/synthèse chimique , Produits biologiques/synthèse chimique , Indoles/synthèse chimique , Acylation , Alkylation , Antinéoplasiques/composition chimique , Produits biologiques/composition chimique , Chromatographie en phase gazeuse , Indoles/composition chimique , Structure moléculaire , Oxindoles
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE